Drugs Made in America AcquisDMAA
13F holders, Q3 2025 (September 30)37holders +5
10new positions
5sold out
1famous investor
$10.27avg. 13F price*
At the end of Q3 2025, 37 institutions reported holding Drugs Made in America Acquis (DMAA) in their 13F filings, up 5 from Q2 2025. 10 opened new positions and 5 sold out. The largest holders were Karpus Management, Inc. ($26.2M), First Trust Capital Management L.P. ($23.0M) and Polar Asset Management Partners Inc. ($19.5M). One famous investor held it David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Drugs Made in America Acquis
- CUSIP
- G2847J104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $13.6M |
| Exits | 5 | $7.2M |
All 13F filers, Q2 2025 → Q3 2025: 2,260,897 shares bought and 1,423,721 shares sold, net +837,176 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Karpus Management, Inc. | 0.83% | Reduce -7.2% | 2,547,667 | $26.2M |
| First Trust Capital Management L.P. | 1.49% | No change | 2,242,500 | $23.0M |
| Polar Asset Management Partners Inc. | 0.57% | No change | 1,900,000 | $19.5M |
| Glazer Capital, LLC | 0.69% | Reduce -0.0% | 1,822,292 | $18.7M |
| Westchester Capital Management, LLC | 0.89% | No change | 1,669,000 | $17.1M |
| Hudson Bay Capital Management LP | 0.11% | Reduce -13.9% | 1,550,000 | $15.9M |
| Wolverine Asset Management LLC | 0.90% | Add +22.2% | 1,249,128 | $12.8M |
| Mizuho Securities USA LLC | 0.23% | Add +19.6% | 1,100,447 | $11.3M |
| Aristeia Capital, L.L.C. | 0.47% | No change | 881,716 | $9.1M |
| D. E. Shaw & Co. | 0.01% | No change | 690,000 | $7.1M |
| Heights Capital Management, Inc. | 2.22% | No change | 650,000 | $6.7M |
| Radcliffe Capital Management, L.P. | 1.11% | Add +316.7% | 528,100 | $5.4M |
| Atw Spac Management LLC | 6.73% | Reduce -12.3% | 500,000 | $5.1M |
| J. Goldman & Co LP | 0.19% | New | 500,000 | $5.1M |
| Boothbay Fund Management, LLC | 0.14% | Reduce -12.3% | 500,000 | $5.1M |
| LMR Partners LLP | 0.10% | No change | 500,000 | $5.1M |
| Toronto Dominion Bank | 0.01% | Reduce -10.0% | 450,000 | $4.6M |
| Whitebox Advisors LLC | 0.27% | No change | 400,000 | $4.1M |
| AQR Arbitrage LLC | 0.14% | Reduce -1.4% | 371,211 | $3.8M |
| Rivernorth Capital Management, LLC | 0.19% | New | 317,998 | $3.3M |
| Context Capital Management, LLC | 0.53% | New | 250,000 | $2.6M |
| Clear Street Group Inc. | 0.01% | — | 209,566 | $2.2M |
| Shaolin Capital Management LLC | 0.29% | Add +50.0% | 150,000 | $1.5M |
| Bulldog Investors, LLP | 0.31% | Add +78.5% | 130,264 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | No change | 119,686 | $1.2M |
| DLD Asset Management, LP | 0.49% | Reduce -39.8% | 113,672 | $1.2M |
| JPMorgan Chase & Co. | 0.00% | New | 99,690 | $1.0M |
| Warberg Asset Management LLC | 3.40% | No change | 92,055 | $945K |
| Periscope Capital Inc. | 0.13% | New | 50,000 | $514K |
| Geode Capital Management, LLC | 0.00% | No change | 45,648 | $469K |
| Dakota Wealth Management | 0.01% | New | 36,400 | $374K |
| HRT Financial LP | 0.00% | New | 27,487 | $282K |
| UBS Group AG | 0.00% | Add +2012000.0% | 20,121 | $207K |
| Sandia Investment Management LP | 0.49% | New | 15,721 | $161K |
| Quarry LP | 0.04% | New | 15,721 | $161K |
| Governors Lane LP | 0.02% | New | 11,200 | $115K |
| Morgan Stanley | 0.00% | Reduce -70.6% | 32 | $329 |
"% of holder's portfolio" is DMAA's weight in each manager's 13F, not the share of Drugs Made in America Acquis the manager owns.